EPOR inhibition enhances the overall glioma death in response to radiotherapy or chemotherapy (p<0.05) relative to scrambled cells, with a total of 83% versus 50% for irradiation, and 88% versus 67% for TMZ treatment (Figure 7B). This evidence concerns the gene EPOR and central nervous system cancer.